ArticleFrontiers in immunology2022

A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.

Zhirui Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.